The Global Predictive Biomarkers Market is predominantly driven by the increase in cancer incidences across the globe, augmenting the applications of biomarkers in cancer diagnosis. Moreover, augmented investments and funding for the advancements for Research and Development in pharmaceutical companies and biotechnology companies by government and non-government bodies are further...